OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies
Fengwen Zhang, Jesse Jenkins, Robson Amparo de Carvalho, et al.
Nature Microbiology (2023) Vol. 8, Iss. 6, pp. 1051-1063
Open Access | Times Cited: 12
Fengwen Zhang, Jesse Jenkins, Robson Amparo de Carvalho, et al.
Nature Microbiology (2023) Vol. 8, Iss. 6, pp. 1051-1063
Open Access | Times Cited: 12
Showing 12 citing articles:
Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access | Times Cited: 3
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access | Times Cited: 3
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 6
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 6
Synergistic Binding of SARS-CoV-2 to ACE2 and Gangliosides in Native Lipid Membranes
Manorama Dey, Anurag Sharma, Garvita Dhanawat, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 907-916
Closed Access | Times Cited: 3
Manorama Dey, Anurag Sharma, Garvita Dhanawat, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 3, pp. 907-916
Closed Access | Times Cited: 3
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Cheng‐Pu Sun, Chi-Wen Chiu, Ping‐Yi Wu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3322-3336
Open Access | Times Cited: 8
Cheng‐Pu Sun, Chi-Wen Chiu, Ping‐Yi Wu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3322-3336
Open Access | Times Cited: 8
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Charles A. Whittaker, Gregory Barnsley, Daniela Olivera Mesa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Charles A. Whittaker, Gregory Barnsley, Daniela Olivera Mesa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
Matthew Gagné, Barbara J. Flynn, Christopher Cole Honeycutt, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Matthew Gagné, Barbara J. Flynn, Christopher Cole Honeycutt, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Screened Fv-Antibodies against the Angiotensin-Converting Enzyme 2 (ACE2) Receptor Neutralizing the Infection of SARS-CoV-2
Jaeyong Jung, Soonil Kwon, Jeong Soo Sung, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3914-3920
Closed Access | Times Cited: 1
Jaeyong Jung, Soonil Kwon, Jeong Soo Sung, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3914-3920
Closed Access | Times Cited: 1
Clinical development of antivirals against SARS-CoV-2 and its variants
Qiaoshuai Lan, Yan Yan, Guangxu Zhang, et al.
Current Research in Microbial Sciences (2023) Vol. 6, pp. 100208-100208
Open Access | Times Cited: 2
Qiaoshuai Lan, Yan Yan, Guangxu Zhang, et al.
Current Research in Microbial Sciences (2023) Vol. 6, pp. 100208-100208
Open Access | Times Cited: 2
[Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia].
Juan Xia, Lijuan DU, Xueli Xi, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 230-235
Closed Access
Juan Xia, Lijuan DU, Xueli Xi, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 230-235
Closed Access
Intranasal delivery of a broadly neutralizing single domain antibody targeting ACE2 protects against SARS-CoV-2 infection
Simon Blachier, I. Fernández, Laurine Conquet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Simon Blachier, I. Fernández, Laurine Conquet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Giant Plasma Membrane Vesicles as Cellular‐Mimics for Probing SARS‐CoV‐2 Binding at Single Particle Level
Manorama Dey, Garvita Dhanawat, Divya Gupta, et al.
ChemistrySelect (2023) Vol. 8, Iss. 33
Closed Access | Times Cited: 1
Manorama Dey, Garvita Dhanawat, Divya Gupta, et al.
ChemistrySelect (2023) Vol. 8, Iss. 33
Closed Access | Times Cited: 1
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways
Matthew Gagné, Barbara J. Flynn, Christopher Cole Honeycutt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Matthew Gagné, Barbara J. Flynn, Christopher Cole Honeycutt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
